Similar Articles
1851 Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy
1852 Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
1853 Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing
1854 Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma
1855 Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma
1856 Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis
1857 Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma
1858 Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma
1859 Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues
1860 Fumagillin treatment of hepatocellular carcinoma in rats: An in vivo study of antiangiogenesis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA